Key result
Local heparin delivery before bailout stenting showed no significant difference in the 30-day composite endpoint compared to standard therapy (21% vs. 0%; P=0.18).
Why the study?
Does local heparin delivery before bailout stenting reduce ischemic complications in patients with suboptimal angioplasty results?
RCT (n=57)
randomized
Yes
Does local heparin delivery before bailout stenting reduce ischemic complications in patients with suboptimal angioplasty results?
Local heparin delivery before bailout stenting for suboptimal angioplasty results did not significantly reduce ischemic complications and may increase complication risk.
No ischemic benefit from local heparin before bailout stenting; challenges prior strategies and does not support adoption.
Bailout stenting for major dissection and threatened closure has high rates of ischemic complications. We performed a randomized trial of local heparin delivery using the infusion sleeve before bailout stenting for suboptimal angioplasty results. In phase I, 20 patients were randomized to local delivery with either 40- or 100-psi infusion pressure. In phase II, 37 patients were randomized to local delivery at 100 psi or standard therapy. Local delivery succeeded in all but one patient; overall there was no significant worsening of intimal dissection. One patient treated with 100-psi drug infusion suffered a perforation after stent placement. There were no significant differences in the composite endpoint of death, MI, CABG, urgent repeat angioplasty, and stent thrombosis at 30 days (21% vs. 0%; P = 0.18). At 6 months, the rates of myocardial infarction in phase II were 27% with local delivery vs. 10% with standard treatment (P = 0.4). Local heparin delivery in dissected vessels may be associated with increased complications and should be approached with caution.
No takes yet. Share an insight, caveat, or question.
Tanguay et al. (2000) conducted an RCT in Suboptimal angioplasty results requiring bailout stenting (n=57). Local heparin delivery using an infusion sleeve vs. Standard therapy was evaluated on Composite of death, MI, CABG, urgent repeat angioplasty, and stent thrombosis at 30 days (p=0.18). Local heparin delivery before bailout stenting showed no significant difference in the 30-day composite endpoint compared to standard therapy (21% vs. 0%; P=0.18).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: